107 related articles for article (PubMed ID: 21524463)
1. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma.
Li Y; Yang HX; Luo RZ; Zhang Y; Li M; Wang X; Jia WH
Ann Thorac Surg; 2011 May; 91(5):1531-8. PubMed ID: 21524463
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
4. Invited commentary.
Wee JO; Colson YL
Ann Thorac Surg; 2011 May; 91(5):1538. PubMed ID: 21524464
[No Abstract] [Full Text] [Related]
5. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
[TBL] [Abstract][Full Text] [Related]
7. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
10. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
[TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
13. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
14. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
15. Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas.
Wen J; Hu Y; Luo KJ; Yang H; Zhang SS; Fu JH
Ann Thorac Surg; 2013 Jan; 95(1):285-90. PubMed ID: 23272845
[TBL] [Abstract][Full Text] [Related]
16. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy.
Cai WJ; Xin PL
Radiother Oncol; 2010 Jul; 96(1):104-7. PubMed ID: 20605246
[TBL] [Abstract][Full Text] [Related]
17. Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.
Yang HX; Hou X; Liu QW; Zhang LJ; Liu JG; Lin P; Fu JH
Ann Thorac Surg; 2012 Jun; 93(6):1861-6. PubMed ID: 22551848
[TBL] [Abstract][Full Text] [Related]
18. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Li LY; Xu XE; Wu JY; Huang Q; Li EM
Eur J Surg Oncol; 2011 Aug; 37(8):669-74. PubMed ID: 21664098
[TBL] [Abstract][Full Text] [Related]
19. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
20. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
